Impact of pharmacist-led medication assessments on opioid utilization

Special Advisory Committee on the Epidemic of Opioid Overdoses. National report: Apparent opioid-related deaths in Canada (January 2016 to September 2018). 2019. Available: https://health-infobase.canada.ca/datalab/national-surveillance-opioid-mortality.htm (accessed May 24, 2019).

Busse J Craigie S Juurlink D , et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ 2017;189:E659-66.

Pringle JL Cochran J Aruru M. Role of pharmacists in the opioid use disorder (OUD) crisis. Res Soc Adm Pharm 2019;15(2):228-9.

Murphy L Chang F Dattani S Sproule B. A pharmacist framework for implementation of the Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Can Pharm J (Ott) 2019;152(1):35-44.

Jacobs SC Son EK Tat C Chiao P Dulay M Ludwig A. Implementing an opioid risk assessment telephone clinic: outcomes from a pharmacist-led initiative in a large Veterans Health Administration primary care clinic, December 15, 2014–March 31, 2015. Subst Abuse 2016;37(1):15-9.

Bauters TGM Devulder J Robays H . Clinical pharmacy in a multidisciplinary team for chronic pain in adults. Acta Clin Belg 2008;63(4):247-50.

Dole EJ Murawski MM Adolphe AB Aragon FD Hochstadt B. Provision of pain management by a pharmacist with prescribing authority. Am J Health Syst Pharm 2007;64(1):85-9.

Pammett R Jorgenson D. Eligibility requirements for community pharmacy medication review services in Canada. Can Pharm J (Ott) 2014;147(1):20-4.

Geurts MME Talsma J Brouwers JRBJ de Gier JJ . Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol 2012;74(1):16-33.

Hatah E Braund R Tordoff J Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol 2014;77(1):102-15.

Holland R Lenaghan E Harvey I , et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 2005;330(7486):293.

Henrich N Tsao N Gastonguay L Lynd L Marra CA. BC Medication Management Project: perspectives of pharmacists, patients and physicians. Can Pharm J (Ott) 2015;148(2):90-100.

Riley K. Enhanced medication management services in the community: a win-win proposal from an economic, clinical and humanistic perspective. Can Pharm J (Ott) 2013;146(3):162-8.

Kolhatkar A Cheng L Chan FKI Harrison M Law MR. The impact of medication reviews by community pharmacists. J Am Pharm Assoc 2016;56(5):513-20.

Jorgenson D Landry E Lysak K Bhimji H. Impact of pharmacist-led medication assessments on medication costs. Can Pharm J (Ott) 2019;152(1):23-7.

American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2015;63(11):2227-46.

Gomes T Mamdani MM Dhalla IA Paterson JM Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011;171(7):686-91.

Dasgupta N Funk MJ Proescholdbell S Hirsch A Ribisl KM Marshall S. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med 2016;17(1):85-98.